|

Depression Clinical Trials in Austin, TX

27 recruiting studies within 50 miles

Phase
Trial Phase Dist.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
Cancer Pain Management Using a Web-based InterventionN/A<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3<1 mi
SAINT in Postpartum Depression (PPD)N/A<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
Confirmatory Efficacy Trial of Attention Bias Modification for DepressionEarly 1<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)Phase 3<1 mi
Clinical Trial on Agitation in Alzheimer's DementiaPhase 2<1 mi
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With DepressionN/A<1 mi
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary CareN/A<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
Establishing Multimodal Brain Biomarkers for Treatment Selection in DepressionPhase 4<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
To Improve Depressive Symptoms Using a Web-AppN/A<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)Phase 2<1 mi
Accelerated Intermittent Theta Burst in Treatment-Naive AdolescentsN/A<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3<1 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorPhase 4<1 mi
Psilocybin rTMS for Treatment Resistant DepressionPhase 2<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 2<1 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolPhase 3<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Phase 3<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)Phase 2<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.